[4-chloro-3-[(2,5-dimethylpyrazol-3-yl)methoxy]-2-methoxyquinolin-6-yl]-bis(2,3-dimethylimidazol-4-yl)methanol
C27H30ClN7O3 — CID 118021824
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-chloro-3-[(2,5-dimethylpyrazol-3-yl)methoxy]-2-methoxyquinolin-6-yl]-bis(2,3-dimethylimidazol-4-yl)methanol
[4-chloro-3-[(2,5-dimethylpyrazol-3-yl)methoxy]-2-methoxyquinolin-6-yl]-bis(2,3-dimethylimidazol-4-yl)methanol (PubChem CID 118021824) has the molecular formula C27H30ClN7O3 and a molecular weight of 536.04 g/mol. Its IUPAC name is [4-chloro-3-[(2,5-dimethylpyrazol-3-yl)methoxy]-2-methoxyquinolin-6-yl]-bis(2,3-dimethylimidazol-4-yl)methanol.
Molecular Properties
| Compound Name | [4-chloro-3-[(2,5-dimethylpyrazol-3-yl)methoxy]-2-methoxyquinolin-6-yl]-bis(2,3-dimethylimidazol-4-yl)methanol |
|---|---|
| PubChem CID | 118021824 |
| Molecular Formula | C27H30ClN7O3 |
| Molecular Weight | 536.04 g/mol |
| Exact Mass | 535.21 |
| IUPAC Name | [4-chloro-3-[(2,5-dimethylpyrazol-3-yl)methoxy]-2-methoxyquinolin-6-yl]-bis(2,3-dimethylimidazol-4-yl)methanol |
| SMILES | COc1nc2ccc(C(O)(c3cnc(C)n3C)c3cnc(C)n3C)cc2c(Cl)c1OCc1cc(C)nn1C |
| InChI | InChI=1S/C27H30ClN7O3/c1-15-10-19(35(6)32-15)14-38-25-24(28)20-11-18(8-9-21(20)31-26(25)37-7)27(36,22-12-29-16(2)33(22)4)23-13-30-17(3)34(23)5/h8-13,36H,14H2,1-7H3 |
| InChIKey | LRMITCOVQZHHAE-UHFFFAOYSA-N |
| XLogP | 3.89 |
| TPSA | 105.04 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 536.04 |
| LogP ≤ 5 | 3.89 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118021824 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.